Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Deng

Showing results (1381-1390 of 1,410) with videos related to

Pageof 141
Sort By:
Environmental Science & Technology|June 16, 2026
High-Resolution Spatiotemporal Characterization of PM<sub>2.5</sub> across On-Road Microenvironments Using Large-Scale Taxi-Based Mobile Monitoring in a Chinese CityXuying Ma, Zelei Tan, Bin Zou, et al.
Journal of the American Chemical Society|March 25, 2026
FeSiB<sub>2</sub>: A Hard Semiconducting Open-Framework Iron Silico-borideJunkai Li, Wenju Zhou, Donghan Jia, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 22, 2023
Sequence Variation of Candida albicans Sap2 Enhances Fungal Pathogenicity via Complement Evasion and Macrophage M2-Like Phenotype InductionLan Lin, Moran Wang, Jingsi Zeng, et al.
Cell Host & Microbe|January 31, 2026
Chemical inhibition of a bacterial immune systemZhiyu Zang, Olivia K Duncan, Dziugas Sabonis, et al.
Med (New York, N.Y.)|February 1, 2025
Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trialLiang Zeng, Huan Yan, Wenjuan Jiang, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2024
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in ChinaHuan Yan, Lianxi Song, Yizhi Li, et al.
Med (New York, N.Y.)|July 10, 2024
A randomized phase 2 study of HLX22 plus trastuzumab biosimilar HLX02 and XELOX as first-line therapy for HER2-positive advanced gastric cancerNing Li, Meng Qiu, Yanqiao Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2024
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective studyZhe Huang, Yuda Zhang, Qinqin Xu, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 29, 2023
Anemoside B4, a new pyruvate carboxylase inhibitor, alleviates colitis by reprogramming macrophage functionQing-Hua Liang, Qiu-Rong Li, Zhong Chen, et al.
Nature Communications|January 9, 2021
SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expressionGuojun Hou, Isaac T W Harley, Xiaoming Lu, et al.
Pageof 141

Showing results (1381-1390 of 1,410) with videos related to

Sort By:
Pageof 141
Environmental Science & Technology|June 16, 2026
High-Resolution Spatiotemporal Characterization of PM<sub>2.5</sub> across On-Road Microenvironments Using Large-Scale Taxi-Based Mobile Monitoring in a Chinese CityXuying Ma, Zelei Tan, Bin Zou, et al.
Journal of the American Chemical Society|March 25, 2026
FeSiB<sub>2</sub>: A Hard Semiconducting Open-Framework Iron Silico-borideJunkai Li, Wenju Zhou, Donghan Jia, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 22, 2023
Sequence Variation of Candida albicans Sap2 Enhances Fungal Pathogenicity via Complement Evasion and Macrophage M2-Like Phenotype InductionLan Lin, Moran Wang, Jingsi Zeng, et al.
Cell Host & Microbe|January 31, 2026
Chemical inhibition of a bacterial immune systemZhiyu Zang, Olivia K Duncan, Dziugas Sabonis, et al.
Med (New York, N.Y.)|February 1, 2025
Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trialLiang Zeng, Huan Yan, Wenjuan Jiang, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2024
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in ChinaHuan Yan, Lianxi Song, Yizhi Li, et al.
Med (New York, N.Y.)|July 10, 2024
A randomized phase 2 study of HLX22 plus trastuzumab biosimilar HLX02 and XELOX as first-line therapy for HER2-positive advanced gastric cancerNing Li, Meng Qiu, Yanqiao Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2024
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective studyZhe Huang, Yuda Zhang, Qinqin Xu, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 29, 2023
Anemoside B4, a new pyruvate carboxylase inhibitor, alleviates colitis by reprogramming macrophage functionQing-Hua Liang, Qiu-Rong Li, Zhong Chen, et al.
Nature Communications|January 9, 2021
SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expressionGuojun Hou, Isaac T W Harley, Xiaoming Lu, et al.
Pageof 141